Nuveen Asset Management, LLC Pardes Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.21 - $2.22 $2,453 - $4,502
-2,028 Reduced 1.87%
106,304 $140,000
Q4 2022

Feb 14, 2023
SELL
$0.85 - $1.69 $16,848 - $33,499
-19,822 Reduced 15.47%
108,332 $183,000
Q3 2022

Nov 14, 2022
BUY
$2.14 - $3.7 $7,830 - $13,538
3,659 Added 2.94%
128,154 $237,000
Q2 2022

Aug 15, 2022
BUY
$2.84 - $8.57 $353,565 - $1.07 Million
124,495 New
124,495 $382,000

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email